Results 191 to 200 of about 2,444,315 (286)

Transforming stroke care: the promise of feedback-guided thrombolytic nanomedicine. [PDF]

open access: yesJ Nanobiotechnology
Wang Y   +6 more
europepmc   +1 more source

Heparan sulfate and glycomimetics: Advances in synthesis and biological applications for post‐stroke neurorepair

open access: yesNeuroprotection, Volume 4, Issue 3, Page 213-228, September 2026.
ECM, extracellular matrix; BDNF, brain‐derived neuroptrophic factor; FGF, fibroblast growth factor; VEGF, vascular endothelial growth factor. Abstract Heparan sulfate, a structurally diverse glycosaminoglycan that is abundant in the central nervous system (CNS), orchestrates essential processes fundamental to neural plasticity, neurorepair, and ...
Mozammel H. Bhuiyan   +3 more
wiley   +1 more source

Magnetic particle clusters with tunable thrombus penetration for enhanced thrombolysis. [PDF]

open access: yesFront Bioeng Biotechnol
Lei Y   +7 more
europepmc   +1 more source

Immunomodulatory Nanozymes as Programmable Redox–Immune Set‐Point Regulators

open access: yesSmall, Volume 22, Issue 53, 21 September 2026.
Conceptual phase space linking reactive oxygen species level/dynamics to immune state, with pathological set‐points for chronic inflammation, tumor escape, and degeneration contrasted against a central healthy redox–immune set‐point. Buffering and amplifying nanozymes are depicted as devices that dial redox tone up or down to steer diseased ...
Sumi Choi   +3 more
wiley   +1 more source

Acute intrapartum deep venous thrombosis: A case report

open access: yes
International Journal of Gynecology &Obstetrics, Volume 174, Issue 3, Page 1680-1682, September 2026.
Faith Arimoro   +2 more
wiley   +1 more source

Right Ventricular Global Longitudinal Strain and 30‐Day Mortality in Intermediate‐Risk Pulmonary Embolism: An External Validation Study

open access: yesEchocardiography, Volume 43, Issue 9, September 2026.
Reduced right ventricular global longitudinal strain (RVGLS) was associated with increased 30‐day mortality in an external cohort of patients with intermediate‐risk pulmonary embolism. RVGLS demonstrated discriminative ability (AUC 0.802), and the previously established 17.7% cutoff was associated with differences in 30‐day survival, supporting its ...
Shunsuke Eguchi   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy